SCHEMBL21294560

SCHEMBL21294560

Nc1cc(Cl)cnc1OCCNC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.36
LIPE Q05469 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAOB P27338 1/20 0.35
PLAU P00749 1/20 0.35
PTGS2 P35354 1/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CCR2 P41597 2/20 0.34
CCR4 P51679 2/20 0.34
MDM2 Q00987 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31251145 0.82 CA12 (0.46) BCHELIPESCN9A
SCHEMBL21294546 0.82 CA12 (0.46) BCHELIPESCN9A
SCHEMBL21294422 0.79 MAPT (0.39) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL26195713 0.75 TSHR (0.38) ALDH1A1MAPK1SMN1; SMN2PLAUCYP3A4
SCHEMBL16585292 0.74 NPC1 (0.42) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL18839618 0.74 ACACB (0.39) HPGDMDM2PTGER4PTGER2
SCHEMBL20795952 0.73 MAPT (0.39) BCHELIPENPC1RAB9AALDH1A1
SCHEMBL18839551 0.72 PLAU (0.49) MAPK1SMN1; SMN2PLAUCYP2C9
SCHEMBL5195760 0.71 CYP3A4 (0.46) PLAUCYP3A4MDM2MEN1KMT2A
SCHEMBL17293197 0.70 CHRNB2 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689366-B2 Compounds for MALT1 degredation CORNELL UNIVERSITY (US) 2020-06-23 US disclosed
EP-3535254-A1 COMPOUNDS FOR MALT1 DEGRADATION Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") (US) 2019-09-11 EP disclosed
US-20190263785-A1 COMPOUNDS FOR MALT1 DEGRADATION CORNELL UNIVERSITY (US) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10689366-B2 Compounds for MALT1 degredation CRBN, NFKB2, NFKB1 BCHE 3446/4885LIPE 3805/4885NPC1 1096/4885
US-20190263785-A1 COMPOUNDS FOR MALT1 DEGRADATION CRBN, NFKB2, NFKB1 BCHE 3680/4885LIPE 3983/4885NPC1 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.